Print
Email
Print Edition StoriesThursday, April 30, 2009
Phase Forward signs multi-year deal with Everest Clinical
By Mass High Tech Staff
MHT's Marc Songini: RI plans launch of cord blood center
MHT's Marc Songini: Mass. bio firms prep for lifting of stem cell ban
Waltham-based Phase Forward, which offers data management solutions for clinical trials and drug safety, has announced a multi-year, multi-million dollar extension of an earlier agreement with contract research organization (CRO) Everest Clinical Research Services Inc.
The original deal was signed in 2007 and had Everest using Phase Forward’s InForm Integrated Trial Management and its hosted Central Designer module Electronic Data Capture solution. The companies did not disclose financial details.
Everest, based in Little Falls, N.J., was established by a team formerly with Pharmacia Corp., and has been an independent CRO since Pharmacia’s acquisition by Pfizer five years ago.
Phase Forward (Nasdaq: PFWD) claims to have more than 90 CRO customers.
Earlier this week, Phase Forward announced another multi-year extension of a license and services agreement involving InForm, this one with Danish health-care company Novo Nordisk .
Last week, Phase Forward said that it had purchased Waban Software, a Cambridge-based clinical data analysis and reporting applications maker, for $14 million cash. The acquisition will form the Waban Software Group within Phase Forward, the companies reported.
For 2008, Phase Forward generated revenue of $170.2 million, a 27 percent increase from $134.3 million in 2007. The company’s net income, however, was $13.8 million for 2008, compared to $29.2 million in 2007.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
